These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7480549

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Influence of repeated administration of cimetidine on the pharmacokinetics and pharmacodynamics of adinazolam in healthy subjects.
    Hulhoven R, Desager JP, Cox S, Harvengt C.
    Eur J Clin Pharmacol; 1988; 35(1):59-64. PubMed ID: 3220095
    [Abstract] [Full Text] [Related]

  • 23. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE, Greenberg HS.
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [Abstract] [Full Text] [Related]

  • 24. The effects of alprazolam, quazepam and diazepam on saccadic eye movements, parameters of psychomotor function and the EEG.
    Blom MW, Bartel PR, de Sommers K, Van der Meyden CH, Becker PJ.
    Fundam Clin Pharmacol; 1990 Feb; 4(6):653-61. PubMed ID: 1982881
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Flumazenil prevents the anxiolytic effects of diazepam, alprazolam and adinazolam on the early acquisition of two-way active avoidance.
    Escorihuela RM, Fernández-Teruel A, Zapata A, Núñez JF, Tobeña A.
    Pharmacol Res; 1993 Feb; 28(1):53-8. PubMed ID: 8234145
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Alprazolam 0.125 mg twice a day improves aspects of psychometric performance in healthy volunteers.
    Bourin M, Colombel MC, Guitton B.
    J Clin Psychopharmacol; 1998 Oct; 18(5):364-72. PubMed ID: 9790153
    [Abstract] [Full Text] [Related]

  • 29. A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam.
    Snyder PJ, Werth J, Giordani B, Caveney AF, Feltner D, Maruff P.
    Hum Psychopharmacol; 2005 Jun; 20(4):263-73. PubMed ID: 15912482
    [Abstract] [Full Text] [Related]

  • 30. Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate following single intravenous infusions of each compound in health volunteers.
    Fleishaker JC, Hulst LK, Smith TC, Friedman H.
    Eur J Clin Pharmacol; 1992 Jun; 42(3):287-94. PubMed ID: 1577047
    [Abstract] [Full Text] [Related]

  • 31. Amnestic and anxiolytic effects of alprazolam in oral surgery patients.
    Coldwell SE, Milgrom P, Getz T, Ramsay DS.
    J Oral Maxillofac Surg; 1997 Oct; 55(10):1061-70. PubMed ID: 9331228
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. N-desmethyladinazolam pharmacokinetics and behavioral effects following administration of 10-50 mg oral doses in healthy volunteers.
    Fleishaker JC, Smith TC, Friedman H, Phillips JP.
    Psychopharmacology (Berl); 1991 Oct; 105(2):181-5. PubMed ID: 1796125
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Increased sensitivity to alprazolam in females with a paternal history of alcoholism.
    Evans SM, Levin FR, Fischman MW.
    Psychopharmacology (Berl); 2000 Jun; 150(2):150-62. PubMed ID: 10907668
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepam.
    DeVane CL, Ware MR, Lydiard RB.
    Psychopharmacol Bull; 1991 Jun; 27(4):463-73. PubMed ID: 1687613
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics and pharmacodynamics of alprazolam following single and multiple oral doses of a sustained-release formulation.
    Fleishaker JC, Phillips JP, Eller MG, Smith RB.
    J Clin Pharmacol; 1989 Jun; 29(6):543-9. PubMed ID: 2754023
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics and psychomotor performance of alprazolam: concentration-effect relationship.
    Wright CE, Sisson TL, Fleishaker JC, Antal EJ.
    J Clin Pharmacol; 1997 Apr; 37(4):321-9. PubMed ID: 9115058
    [Abstract] [Full Text] [Related]

  • 40. Effects of single doses of alprazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.
    Linnoila M, Stapleton JM, Lister R, Moss H, Lane E, Granger A, Eckardt MJ.
    Eur J Clin Pharmacol; 1990 Apr; 39(1):21-8. PubMed ID: 2276384
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.